Two Sigma Investments, LP Tenaya Therapeutics, Inc. Transaction History
Two Sigma Investments, LP
- $42.3 Billion
- Q3 2024
A detailed history of Two Sigma Investments, LP transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 54,714 shares of TNYA stock, worth $79,335. This represents 0.0% of its overall portfolio holdings.
Number of Shares
54,714
Previous 107,579
49.14%
Holding current value
$79,335
Previous $333,000
68.47%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding TNYA
# of Institutions
96Shares Held
56.3MCall Options Held
900Put Options Held
400-
Column Group LLC San Francisco, CA9.4MShares$13.6 Million26.09% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.98MShares$10.1 Million0.19% of portfolio
-
Casdin Capital, LLC New York, NY6.73MShares$9.76 Million1.01% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$5.91 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.21MShares$4.66 Million0.0% of portfolio
About Tenaya Therapeutics, Inc.
- Ticker TNYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,364,700
- Market Cap $60M
- Description
- Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...